Catheters Market Prepares for Significant Expansion: Anticipating a Growth Rate of 7-8% by 2028
The rising prevalence of chronic diseases associated
with urinary disorders and kidney failure, rising demand for minimally invasive
surgical procedures, rising cases of incontinence caused by the global rise in
the geriatric population, and technological advancements in catheters are the
key factors driving the market. Fill out a simple inquiry for a sample report
to discover more about the research.
A catheter is a type of medical equipment
that is used for therapeutic treatments, disease management, or surgical
operations. It is introduced into the body to help with bodily fluid evacuation
or to give drugs.
Urological Catheters are becoming more
popular as the global prevalence of urinary incontinence rises.
Urinary incontinence is a global
health and social concern, affecting about 400 million individuals worldwide.
This figure is continually rising, and globally, one in every three women over
the age of 35 and one in every four males over the age of 40 suffer from
incontinence.
The rising global
prevalence of urine incontinence is expected to drive the global market in the
future years. According to figures from the Association for Women's Health
Care, women are twice as likely as males to have urine incontinence. Stress
incontinence affects one-third of women over the age of 35, and it affects
around half of all women over the age of 65. In addition, 1 million US males
suffer from stress urinary incontinence, while 18 million US women suffer from
involuntary pee leakage. These results show that the population has a greater
prevalence of stress urine incontinence. The growing prevalence of urine
incontinence throughout the world is an important factor that is likely to
increase global use of urological catheters.
Technological Progress Fuels the
Global Catheters Market
Catheter sales are expected to rise as
demand for minimally invasive treatments rises as a result of technology
improvements. The use of antimicrobial coatings and smaller catheters to avoid
restenosis, or the return of blood artery constriction in later phases, is a
significant advancement. These operations, which have become regular practices
in general surgery due to the availability of improved technology and new
coated catheters, are being driven by peripheral disorders, which are strongly
connected to chronic ailments such as diabetes. Notably, patients' growing
preference for angioplasty over traditional operations, owing to its minimally
invasive nature and superior results, has contributed to the increased use of
minimally invasive treatments and favored market growth.
Citing the lucrative prospects of the
market, several players have launched technologically advanced products in the
market, which are expected to further drive the market. For instance,
·
In
May 2023, Abbott received FDA approval for their Tactiflex ablation
catheter, which was designed to treat irregular cardiac rhythms. This catheter,
which has a unique flexible electrode tip and contact force sensing, is
designed to treat people who have atrial fibrillation.
Catheters Market
Competitive Landscape
Some of the key players operating
in the market include Medtronic, Teleflex Incorporated, Abbott, B.
Braun Melsungen AG, Edwards Lifesciences Corporation, Coloplast, Johnson &
Johnson Services, Terumo Corporation, Becton, Dickinson and Company, Boston
Scientific Corporation, ConvaTec Group, Hollister Incorporated, Stryker, Cook
Medical and Merit Medical Systems, among others.
Organic and inorganic growth
strategies used by firms to get a market foothold
To improve their market position and
increase their client base, players in this market are pursuing organic and
inorganic growth methods such as getting regulatory permissions, releasing new
products, making strategic investments, and pursuing mergers and acquisitions.
For instance,
·
In
February 2023, Teleflex disclosed that the
510(k) clearance from the U.S. FDA had been granted to its Triumph Catheter.
This catheter, distinguished by its innovative design facilitating precise wire
advancement and clear visualization, marks a significant milestone
·
In
December 2022, Boston Scientific revealed a strategic
investment to acquire a majority share in the Chinese medical technology firm
Acotec Scientific Holdings Limited. Acotec is recognized in China for its
thrombus aspiration catheters, and RF ablation technologies. Boston
Scientific's objective is to enhance its regional standing through this
strategic partnership.
·
In
2022, B.
Braun Melsungen introduced Dican Flex,
single-use safety catheters for peripheral vascular access in extracorporeal
blood purification therapy
The
Catheter Market is expected to gain traction in the future years as a result of
the rising acceptance of antimicrobial catheters, greater awareness and
adoption of catheters in emerging regions, the use of advanced materials in
catheters, and home healthcare souring catheter innovation.
Get
Detailed Insights on the Catheter Market @ https://meditechinsights.com/catheter-market/
About
Medi-Tech Insights
Medi-Tech
Insights is a healthcare-focused business research & insights firm. Our
clients include Fortune 500 companies, blue-chip investors & hyper-growth
start-ups. We have successfully completed 100+ projects in Digital Health,
Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
Contact:
Ruta Halde
Associate,
Medi-Tech Insights
+32 498 86
80 79
info@meditechinsights.com
Comments
Post a Comment